Abstract
In our recent publication (Zheng et al. PLoS ONE) we described the identification of annexin A2 as a new pancreatic cancer associated tumor antigen. Its involvement in pancreatic cancer progression and metastases supports its role as an antigenic target for the development of both therapeutic antibody and T cell immunotherapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 112-114 |
| Number of pages | 3 |
| Journal | OncoImmunology |
| Volume | 1 |
| Issue number | 1 |
| DOIs |
|
| State | Published - 2012 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Oncology